Search form
Search
contact us
Navigation
home
boards
Jobs
job ratings
cp wire
medtech news
pharmagather
catering
advertise
whistleblower info
pharmaceutical fraud
medical device | DME fraud
clinical lab fraud
False Claims Act
Legal Help
login/register
You are here
Home
»
companies
» Humira
Humira
FDA rejects Teva’s high-potency biosimilar of Humira again
Pharmaphorum
Fri, 04/14/23 - 10:37 am
Teva Pharmaceutical
Alvotech
biosimilars
FDA
Humira
In upcoming skin disease clash, doctors see Novartis' Cosentyx as an underdog
Fierce Pharma
Tue, 04/11/23 - 10:04 am
Novartis
Cosentyx
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Spotlight – following Humira in hidradenitis suppurativa
EP Vantage
Tue, 04/4/23 - 10:10 am
AbbVie
Humira
hidradenitis suppurativa
UCB Pharma
Bimzelx
MoonLake Immunotherapeutics
AAD 2023 – UCB and Acelyrin take aim at hidradenitis suppurativa
EP Vantage
Tue, 03/21/23 - 09:54 am
AAD
hidradenitis suppurativa
AbbVie
Humira
UCB Pharma
Bimzelx
Acelyrin
izokibep
AbbVie's Humira, 5 Pfizer drugs among those with price hikes that exceeded inflation rate
Fierce Pharma
Wed, 03/15/23 - 11:25 am
Pfizer
AbbVie
Humira
drug pricing
inflation
AbbVie braces for 'greater erosion' of Humira franchise in second half of this year
Endpoints
Tue, 03/7/23 - 10:22 pm
AbbVie
Humira
Rinvoq
AbbVie CEO Gonzalez scored $26M in 2022 pay as cash cow Humira neared patent cliff
Fierce Pharma
Tue, 03/7/23 - 11:55 am
AbbVie
Pharma CEOs
executive pay
Humira
Richard Gonzalez
Could This Humira Biosimilar Be a Winner for Amgen?
Motley Fool
Fri, 03/3/23 - 11:48 am
Amgen
biosimilars
Amjevita
Humira
Big pharma’s looming threat: a patent cliff of ‘tectonic magnitude’
BioPharma Dive
Tue, 02/21/23 - 11:05 am
Big Pharma
patents
patent cliff
biosimilars
AbbVie
Humira
Merck
Keytruda
Bristol Myers Squibb
Opdivo
Years after the first US biosim launches, doctors still have their concerns: survey
Fierce Pharma
Thu, 02/16/23 - 04:49 pm
biosimilars
PBMs
physicians
AbbVie
Humira
Amgen
Amjevita
AbbVie talks next steps as first Humira competitor makes it to market
Endpoints
Thu, 02/9/23 - 06:01 pm
AbbVie
Humira
biosimilars
Rick Gonzalez
AbbVie opens up to bigger deals as competition heats up
Endpoints
Mon, 02/6/23 - 06:19 pm
AbbVie
Humira
Amgen Adopts A Two-Price Strategy For The U.S.’s First Marketed Humira-Referenced Biosimilar, Amjevita
Forbes
Wed, 02/1/23 - 10:41 am
Amgen
Amjevita
AbbVie
Humira
biosimilars
drug pricing
Amgen launches Humira biosimilar, releases Q4 earnings report
Medical Marketing and Media
Tue, 01/31/23 - 11:21 pm
Amgen
Humira
biosimilars
earnings
AbbVie
Amjevita
Humira biosimilars arrive in the US, as Amgen launches first copycat to AbbVie’s blockbuster drug
BioPharma Dive
Tue, 01/31/23 - 12:37 pm
AbbVie
Humira
biosimilars
Amgen
The end of the Humira era
EP Vantage
Mon, 01/30/23 - 10:46 am
AbbVie
Humira
patents
biosimilars
Merck
Keytruda
AbbVie Is Set to Lose on Its Biggest Blockbuster. Here's Why You Shouldn't Worry.
Motley Fool
Sun, 01/22/23 - 01:01 pm
AbbVie
Humira
biosimilars
Amgen prepped to take first slice of AbbVie’s US Humira pie
BioProcess International
Wed, 01/18/23 - 11:00 pm
Amgen
Humira
biosimilars
adalimumab
Amjevita
Looking past Humira, AbbVie boosts sales forecasts for successor drugs
BioPharma Dive
Wed, 01/11/23 - 12:22 pm
JPMHC 2023
AbbVie
Richard Gonzalez
Pharma CEOs
Humira
Skyrizi
Rinvoq
The Big Three PBMs’ 2023 Formulary Exclusions: Observations on Insulin, Humira, and Biosimilars
Drug Channels
Tue, 01/10/23 - 10:44 am
PBMs
Caremark
CVS Health
Express Scripts
Cigna
OptumRx
United Health
formularies
insulin
biosimilars
Humira
Pages
« first
‹ previous
1
2
3
4
5
6
7
8
9
…
next ›
last »